High expression of TCN1 is a negative prognostic biomarker and can predict neoadjuvant chemosensitivity of colon cancer.

Scientific Reports
Guang-Jie LiuGui-Ying Wang

Abstract

Transcobalamin (TCN1) is a vitamin B12 (cobalamin)-binding protein that regulates cobalamin homeostasis. Recent studies and bioinformatic analyses have found that TCN1 is highly expressed in cancer tissues and is associated with tumour aggressiveness and poor prognosis. The present study aimed to detect TCN1 as a novel biomarker for prognosis and chemosensitivity of colon cancer. Next-generation sequencing showed that TCN1 was one of several upregulated mRNAs in colon cancer, which was verified by further bioinformatics analyses. Western blotting (n = 9) and quantitative real time polymerase chain reaction (qRT-PCR, n = 30) revealed that TCN1 was highly expressed in colon cancer tissues at both the protein and mRNA level. A total of 194 cases of colon cancer were examined by immunohistochemistry and revealed that TCN1 expression level was related to advanced stages (P < 0.005). Kaplan-Meier analysis verified that patients with lower TCN1 expression usually had longer overall survival (P = 0.008). In addition, TCN1 was highly expressed in pulmonary metastatic tumour tissues (n = 37, P = 0.025) and exhibited higher levels in right-sided colon cancer than in left-sided colon cancer (P = 0.029). TCN1 expression in specimens that ha...Continue Reading

References

Feb 6, 1975·The New England Journal of Medicine·R Carmel
Feb 1, 1989·Pathology, Research and Practice·K OgawaT Takeda
Mar 1, 1988·Journal of Clinical Pathology·H KudoM Inada
Mar 21, 2003·Virchows Archiv : an International Journal of Pathology·A AlkushiC B Gilks
Mar 26, 2003·QJM : Monthly Journal of the Association of Physicians·J G Ray, H J Blom
Apr 17, 2008·Cancer Research·Robert WaibelPius August Schubiger
Dec 3, 2011·European Journal of Pediatrics·Sinasi Ozsoylu
Jul 17, 2012·The British Journal of Nutrition·Marcella MartinelliRossella Solmi
Jun 22, 2013·British Journal of Cancer·T BoyleJ Heyworth
Jan 22, 2015·Nucleic Acids Research·Matthew E RitchieGordon K Smyth
Jun 2, 2017·International Journal of Cancer. Journal International Du Cancer·Eugenia H MirantiGwen Murphy
Jan 24, 2019·Journal of Cellular Biochemistry·Hui ZhangJifeng Feng

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
PCR
RNA-seq
electrophoresis

Software Mentioned

R
Prism5
SPSS
Image J
GSEA
limma
ggplot2
Linkfinder
R Software
pheatmap

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis